Suppr超能文献

成功的变应原特异性免疫疗法:通过“接种疫苗”诱导无反应性

Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by 'Vaccination'.

作者信息

Bachmann Martin F, Vogel Monique, Speiser Daniel E

机构信息

Department of Biomedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.

Department of Rheumatology and Immunology, University Hospital of Bern, 3010 Bern, Switzerland.

出版信息

Vaccines (Basel). 2023 Dec 14;11(12):1852. doi: 10.3390/vaccines11121852.

Abstract

The mechanisms of action of allergen-specific immunotherapy (AIT) are often referred to as the induction of 'tolerance'. However, immunological 'tolerance' is defined as an alteration in the function or composition of immune cells. For AIT, this is not always the case, because it can also induce allergen-specific IgG antibodies that block allergic responses. To include all possible mechanisms that may mediate successful AIT, it is advantageous to use the scientific term 'unresponsiveness' instead of 'tolerance'. In praxis, the term 'vaccination' is also appropriate, as AIT medications are specialized vaccines.

摘要

变应原特异性免疫疗法(AIT)的作用机制通常被称为诱导“耐受”。然而,免疫“耐受”被定义为免疫细胞功能或组成的改变。对于AIT来说,情况并非总是如此,因为它还可以诱导阻断过敏反应的变应原特异性IgG抗体。为了涵盖所有可能介导成功AIT的机制,使用科学术语“无反应性”而非“耐受”是有利的。实际上,“疫苗接种”这个术语也适用,因为AIT药物是特殊的疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/10748047/20c1b76894c9/vaccines-11-01852-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验